Randomised study of rituximab (IDEC C2B8) in patients with relapsed follicular lymphoma prior to high dose therapy as in vivo purging and to maintain remission following high dose therapy
Latest Information Update: 27 Oct 2005
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 27 Oct 2005 New trial record.